RAS

Divarasib View larger

Divarasib

AT9972

CAS 2417987-45-0

More details

Molarity Calculation Cart®

HOW TO ORDER

$208.00

$208.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $93.60 Total: $9,360.00
150 $108.16 Total: $5,408.00
125 $126.88 Total: $3,172.00
110 $149.76 Total: $1,497.60
15 $176.80 Total: $884.00

Data sheet

Molecular FormulaC29H32ClF4N7O2
Molecular Weight622.06
CAS Numbers2417987-45-0
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC[C@H]1CN(CCN1c1nc(OC[C@@H]2CCCN2C)nc2c(F)c(c(Cl)cc12)-c1nc(N)cc(C)c1C(F)(F)F)C(=O)C=C
ReferencesMeng L, et al. Assessment of KRAS G12C Target Engagement by a Covalent Inhibitor in Tumor Biopsies Using an Ultra-Sensitive Immunoaffinity 2D-LC-MSMS Approach. Anal Chem. 2022;94[37] 12927-12933.

More info

Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 ?M. Divarasib irreversibly locks KRAS G12C oncoprotein in an inactive state and inhibits tumor cell growth. It is being investigated for use in solid tumors, including non-small cell lung and colorectal cancers and other types of cancer.